Providing true next-gen microscopy, the compact, inverted design allows imaging in a wide range of labware and settings, including live cell imaging in incubators, hoods, and other challenging locations.
Etaluma is also establishing a range of OEM arrangements with other companies involving its optical components, microscopy systems, private-label LS Microscopes and accessories. Custom designs are also possible by Etaluma’s experienced Engineering team.
Chris Shumate, Ph.D.
Chief Executive Officer and Co-Founder
Robert (Kenji) Levin
Chief Technology Officer- Emeritus
Director of Sales
Christina has over 30 years in the sales and management of clinical and research tools for life sciences. She has worked for a variety of instrumentation and automation providers from start-ups to Danaher. Christina brings the technical and account management skills required to support the Etaluma technology offering.
Chief Financial Officer
Chief Technology Officer
Brian Rasnow, Ph.D.
Board Member and Co-Founder
Walter (Lane) Niles, Ph.D.
Board Member and Co-Founder
Scientific Advisory Board
Alex Zambon, Ph.D.
Alex Zambon, Ph.D., is an Associate Professor in the Department of Biopharmaceutical Sciences at Keck Graduate Institute, Claremont CA. He is a systems biologist with over twenty years experience in live cell imaging, molecular pharmacology, and systems biology. His laboratory focuses on the transcriptional circuits that drive cell fate decisions in cardiac progenitor cells. Alex received his Ph.D. in Biomedical Sciences at the University of California, San Diego. His post-doctoral training was in Genomics at the Gladstone Institutes/University of California, San Francisco.
Mike Sjasstad, Ph.D.
Mike Sjaastad, Ph.D., is Director of Development and Strategy at Biosero. He is responsible for corporate and marketing strategies, product planning and partner relations. He also helped to form the Biosero Strategic Advisory board and serves as a board member. Before joining Biosero, Mike was an independent consultant providing corporate and marketing strategy, technology prospecting and product positioning for small companies and startups. Clients include: Biotek, Notable Labs, IntelliCyt Corporation, Etaluma Biosciences and PhenoVista Bioscience. He has a track record of strategic positions at well-known biotech instrumentation companies, including Business Development at Molecular Devices and IntelliCyt. Mike has a strong scientific background and led the cell biology and drug discovery screening department at Hyseq Pharmaceuticals. Mike earned a bachelor’s degree from Swarthmore College, a doctorate in cell physiology from University of California, Berkeley and participated in post-doctoral training at Stanford University.